Sandra Matsumoto

Title: Sandra Matsumoto: Innovator in Biochip Technology

Introduction

Sandra Matsumoto is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biochip technology, particularly through her innovative patent that enhances biomolecular assays. Her work is instrumental in advancing the capabilities of biochips, which are crucial for various applications in biotechnology and medicine.

Latest Patents

Sandra holds a patent for a groundbreaking invention titled "Three Dimensional Format Biochips." This patent describes a biochip formed with a plurality of optically clear hydrogel cells attached to the top surface of a solid substrate in the form of an array. Each cell is constructed from a hydrogel of polyethylene glycol, polypropylene glycol, or a copolymer thereof, featuring reactive isocyanate groups. The biochip is designed to immobilize different binding entities within these cells, allowing for selective hybridization or sequestration of target biomolecules. This innovative approach enables the creation of biochips capable of assaying multiple target biomolecules simultaneously.

Career Highlights

Sandra is currently associated with Biocept, Inc., where she continues to develop and refine her biochip technology. Her work at Biocept has positioned her as a key player in the biotechnology sector, contributing to advancements that have the potential to revolutionize diagnostic methods.

Collaborations

Throughout her career, Sandra has collaborated with notable colleagues, including Roberto Fagnani and Soonkap Hahn. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Sandra Matsumoto's contributions to biochip technology exemplify her dedication to innovation in the field of biotechnology. Her patent for three-dimensional biochips represents a significant advancement that could lead to improved diagnostic capabilities.